Vancouver, British
Columbia, Canada -- August 27, 2019 -- InvestorsHub NewsWire -- The
Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE:
YG3) is pleased to
announce that it has entered into a distribution and licensing
agreement dated August 25, 2019 with 2699598 Ontario Corp. DBA
Melorganics Hellas ("Melorganics") for European rights to six
product formulas for CBD infusion for a fee of
$900,000.
Wright & Well to Launch in Europe
Yield has agreed to
license to Melorganics in perpetuity the non exclusive rights to
formulas and know-how to manufacture and distribute CBD foot cream,
CBD body oil, CBD muscle relief balm, CBD body exfoliant, CBD
relief gel and CBD hand cream. The formulas may be developed by
Melorganics into products infused with CBD and other cannabinoids
and distributed throughout the European Union under one brand to be
developed by Melorganics (the "Brand").
Yield shall have approval
on the Brand and packaging of the products. The $900,000 fee is due
within one week and may be paid by the issuance of Melorganics
Units to Yield. Upon being issued Melorganics Units, Yield shall
own approximately 18% of Melorganics and shall have the right to
appoint a Director to the Board of Directors of Melorganics. The
value of the Melorganics Units are based on the most recent private
placement into Melorganics.
"We are excited to expand
our relationship with Melorganics to bring our CBD products into
Europe both as a new brand to be developed and also through the
Wright & Well brand," says Penny Green, CEO of Yield Growth.
"The quality of our products and the strength of our brands allow
us to continue to generate revenue and build our assets to bring
value to our shareholders."
Yield Growth has also
agreed to grant Melorganics exclusive distribution rights to the
Wright & Well brand of CBD products for the territory of Greece
and Cyprus for a term of two years for a fee of $100,000, payable
after a definitive distribution agreement is signed between the
parties and after at least 3 Wright & Well products have been
registered for sale within the European Union.
As previously announced,
Melorganics was appointed as the exclusive retail distributor and
non-exclusive e-commerce distributor for Yield Growth's Urban Juve
products in Greece and Cyprus. To maintain exclusivity in the
territory, Melorganics must purchase a minimum amount of Urban Juve
products of $300,000 in Year 1 and $500,000 in each subsequent
year.
"We are delighted to
partner with Yield Growth and now also have access to the Wright
& Well Brand. Multiple SKUs is the best way to enter any
market. Now when the product lines are also outstanding in quality,
you really can't go wrong," says Tom Vachliotis, President of
Melorganics Hellas.
Yield Growth is in the
process of registering all of its Urban Juve products for sale in
the European Union with 2 products approved to-date and 9 more
anticipated to complete registration in the fall.
Yield Growth announces a
financing of $500,000 through the issuance of special warrants at
$0.30 convertible into units consisting of one share and one
warrant to purchase an additional share at $0.35 for a period of
two years.
About
Melorganics
Melorganics Hellas plans
to enter the Greek and Cypriot markets with a full line of CBD
products. The company is in the process of securing exclusive
rights and strategic alliances with leading companies both in
Greece and Canada; companies that are focused on the development of
unique health products and nutraceuticals utilizing cannabis and
botanical oils. The company is founded by Athanasios (Tom)
Vachliotis (a Greek and Canadian Citizen), and John Philpott, who
both have proven success in different business ventures. Vachliotis
has deep ties to Greece and many past business successes. Philpott
is the CEO of CanAm Physician Recruiting Inc., Canada's premier
physician placement firm. He was the CEO of Canabo Medical Corp.,
which obtained a public listing in 2017 and merged in 2018 with
Aleafia Health Inc. in a transaction valued at $40 million and
resulting in a combined operation with a market cap over $200
million. In 2019, the TSX.V announced Aleafia as one of the top 50
best run companies listed on the exchange for
2018.
About The Yield
Growth Corp.
The Yield Growth Corp.
develops, manufactures and distributes cannabis and hemp infused
product brands Urban Juve and Wright & Well and has a catalogue
of over 200 wellness and beauty formulas. It intends to disrupt the
international wellness market, which is a $4.2 trillion global
economy, according to the Global Wellness Institute, by connecting
ancient healing with modern science and technology. Its management
team has deep experience with global brands including Johnson &
Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy,
Aritzia, Coca-Cola and Pepsi Corporation. Yield Growth serves
mainstream luxury consumers who seek sophisticated wellness
products. Its flagship consumer brand, Urban Juve, has proprietary,
patent-pending extraction technology and has 12 patents pending.
Yield Growth is building robust international distribution channels
and has multiple revenue streams including services, licensing and
product sales.
For more
information about Yield Growth,
visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visit www.urbanjuve.com and #findyourjuve across
social platforms to learn, engage and shop.
Investor
Relations Contacts:
Penny Green, President
& CEO
Kristina Pillon, Investor
Relations
invest@yieldgrowth.com
1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677
The Canadian
Securities Exchange has not reviewed, approved or disapproved the
content of this news release.
Cautionary
Statement Regarding Forward-Looking
Statements
This press release
includes forward-looking information and statements (collectively,
"forward looking statements") under applicable Canadian securities
legislation. Forward-looking statements are necessarily based upon
a number of estimates, forecasts, beliefs and assumptions that,
while considered reasonable, are subject to known and unknown
risks, uncertainties, and other factors which may cause the actual
results and future events to differ materially from those expressed
or implied by such forward-looking statements. Such risks,
uncertainties and factors include, but are not limited to: risks
related to the development, testing, licensing, intellectual
property protection, and sale of, and demand for, Urban Juve,
Wright & Well, and UJ Beverages products, general business,
economic, competitive, political and social uncertainties, delay or
failure to receive board or regulatory approvals where applicable,
and the state of the capital markets. Yield Growth cautions readers
not to place undue reliance on forward-looking statements provided
by Yield Growth, as such forward-looking statements are not a
guarantee of future results or performance and actual results may
differ materially. The forward-looking statements contained in this
press release are made as of the date of this press release, and
Yield Growth expressly disclaims any obligation to update or alter
statements containing any forward-looking information, or the
factors or assumptions underlying them, whether as a result of new
information, future events or otherwise, except as required by
law.